BridgeBio reports Q3 2026 results, three PDUFA dates ahead and new Phase 3 study startsOct 29Quarterly updateBridgeBio Pharma, Inc.
BridgeBio secures $1 billion preferred equity deal led by Sixth StreetJul 2FinancingBridgeBio Pharma, Inc.